These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28687916)

  • 1. Amide proton transfer imaging for differentiation of benign and atypical meningiomas.
    Joo B; Han K; Choi YS; Lee SK; Ahn SS; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2018 Jan; 28(1):331-339. PubMed ID: 28687916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide proton transfer and chemical exchange saturation transfer MRI differentiates between growing and non-growing intracranial meningiomas: a pilot study.
    Koike H; Morikawa M; Ideguchi R; Uetani M; Hiu T; Matsuo T
    Clin Radiol; 2022 Apr; 77(4):e295-e301. PubMed ID: 35090693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Chemical Exchange Saturation Transfer Imaging of Amide Proton Transfer Differentiates between Cerebellopontine Angle Schwannoma and Meningioma: Preliminary Results.
    Koike H; Morikawa M; Ishimaru H; Ideguchi R; Uetani M; Hiu T; Matsuo T; Miyoshi M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the effects of water proton concentration and water T
    Lee DH; Heo HY; Zhang K; Zhang Y; Jiang S; Zhao X; Zhou J
    Magn Reson Med; 2017 Feb; 77(2):855-863. PubMed ID: 26841096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
    Debnath A; Gupta RK; Singh A
    Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing amide proton transfer imaging in haemorrhage brain lesions using 3T MRI.
    Jeong HK; Han K; Zhou J; Zhao Y; Choi YS; Lee SK; Ahn SS
    Eur Radiol; 2017 Apr; 27(4):1577-1584. PubMed ID: 27380905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer-weighted imaging with a short acquisition time based on a self B0 correction using the turbo spin echo-Dixon method: A phantom study.
    Tokunaga C; Wada T; Togao O; Kobayashi K; Kato T
    Magn Reson Imaging; 2024 Jul; 110():69-77. PubMed ID: 38614223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
    Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
    Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI).
    Su C; Zhao L; Li S; Jiang J; Cai K; Shi J; Yao Y; Ao Q; Zhang G; Shen N; Hu S; Zhang J; Qin Y; Zhu W
    Eur Radiol; 2019 Mar; 29(3):1203-1210. PubMed ID: 30105412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of progression in skull base meningiomas: additional benefits of apparent diffusion coefficient value.
    Ko CC; Lim SW; Chen TY; Chen JH; Li CF; Shiue YL
    J Neurooncol; 2018 May; 138(1):63-71. PubMed ID: 29353434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Meningiomas and Gliomas by Amide Proton Transfer Imaging: A Preliminary Study of Brain Tumour Infiltration.
    Zhang HW; Liu XL; Zhang HB; Li YQ; Wang YL; Feng YN; Deng K; Lei Y; Huang B; Lin F
    Front Oncol; 2022; 12():886968. PubMed ID: 35646626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MR Morphology and Diffusion-Weighted Imaging in the Evaluation of Meningiomas: Radio-Pathologic Correlation.
    Ranabhat K; Bishokarma S; Agrawal P; Shrestha P; Panth R; Ghimire RK
    JNMA J Nepal Med Assoc; 2019; 57(215):37-44. PubMed ID: 31080244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging-based 3-dimensional fractal dimension and lacunarity analyses may predict the meningioma grade.
    Park YW; Kim S; Ahn SS; Han K; Kang SG; Chang JH; Kim SH; Lee SK; Park SH
    Eur Radiol; 2020 Aug; 30(8):4615-4622. PubMed ID: 32274524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
    Togao O; Yoshiura T; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Suzuki Y; Suzuki SO; Iwaki T; Hata N; Mizoguchi M; Yoshimoto K; Sagiyama K; Takahashi M; Honda H
    Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.